Shadera Slatter

Statistics

Publications

Citations

H-Index

Active since

2023

Affiliations

University of California, San Francisco(Current)

Shadera Slatter is an author at University of California, San Francisco specializing in therapeutic tyrosine kinase inhibitors, tyrosine kinase inhibitors, and cancer pharmacology.

Publications per year

2023–2024

Publications

ALK Inhibitor Treatment Patterns and Outcomes in Real-World Patients with ALK-Positive Non-Small-Cell Lung Cancer: A Retrospective Cohort Study

Michelle Wang, Shadera Slatter, Jesse Sussell et al. · Targeted Oncology · 2023 · 18 citations · Full text

Medicine, Oncology, Pharmacology +15

Large Language Models Outperform Traditional Natural Language Processing Methods in Extracting Patient-Reported Outcomes in Inflammatory Bowel Disease

Perseus V. Patel, Conner Davis, Amariel Ralbovsky et al. · Gastro Hep Advances · 2024 · 13 citations · Full text

Computing, Biomedical Informatics, Health Informatics +17

1–2 of 2